The largest database of trusted experimental protocols

Accucore aq c18 column

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Accucore aQ C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of polar and non-polar compounds. The column features a 2.6 μm particle size and a carbon-clad silica stationary phase, which provides efficient and reproducible chromatographic separations.

Automatically generated - may contain errors

5 protocols using accucore aq c18 column

1

Dionex Ultimate 3000 RSLC for Metabolite Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Dionex Ultimate 3000 RSLC system (Thermofisher) combined with an Accucore aQ C18 column (150 mm × 2.1 mm, 2.6 μm, Thermo fisher) was used in the sample separation process, and the separation speed was set at 0.3 μL/min for all the gradients. 1 μL of injection volume and a constant temperature of (25 ± 1) °C were adopted in the column. The eluents were A, water with 0.1% formic acid (v/v) and B, methanol, and the gradient program was as follows: 0–6 min, 8–40% B; 6–8 min, 40–100% B; 8–10 min, 100% B; 10–11 min, 100–8% B; 11–13 min, 8% B.
+ Open protocol
+ Expand
2

UHPLC-ESI-Orbitrap MS Analysis of Additives

Check if the same lab product or an alternative is used in the 5 most similar protocols
An UHPLC-ESI-Orbitrap MS system consisted of an UltiMate 3,000 pump, a Q Exactive mass spectrometer and a accucore aQ C18 column (2.1 × 150 mm, 2.6 μm particle size, Thermo Fisher Scientific, Rockford, IL, US) were utilized. The column was maintained at 35 °C and the flow rate was set at 0.5 mL/min. A gradient elution containing 0.1% formic acid with 20 mM ammonium acetate (A), and acetonitrile with 0.1% formic acid (B) was applied. The gradient was hold on 1% (B) for first 1 min and then increased from 1 to 99% (B) over the next 8 min. The eluent was remained for the next 7 min, and then mobile phase (B) was retained to 1% over the next 0.1 min, and this was followed by a 2.9 min re-equilibration period at 1% (B) prior to the next injection. The injection volume was 5 μL. The mass spectrometer was operated at ESI positive (3.5 kV) and negative (2.5 kV) mode. Resolution was set at 70,000 (defined at m/z = 200 and was set at full width at half maximum, FWHM). The precursor list was built by direct infusion mass spectrometry of each individual additive standard at concentration of 1 ppm.
+ Open protocol
+ Expand
3

Metabolomic Analysis Using UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ultra-high-performance liquid chromatography-mass spectrometry (UPLC-MS) analysis of metabolites was performed on an AB SCIEX LC-30A-Triple TOF 5600+ ESI MS system (AB SCIEX, Boston, MA, USA) equipped with a Shim-Pack Velox C18 column (2.7 μm, 150 mm × 2.1 mm, SHIMADZU, Japan), and a Thermo QE Focus instrument (Thermo Fisher Scientific, Waltham, MA, USA) with an Accucore AQ C18 column (2.6 μm, 150 mm × 2.1 mm, Thermo Fisher Scientific, Waltham, MA, USA). High-resolution electrospray ionization mass spectrometry (HRESIMS) data of novel metabolites were acquired by a Thermo Scientific Q Exactive mass spectrometer. Analytical high-performance liquid chromatography (HPLC) and semipreparative HPLC were carried out on an Agilent 1100 series system (Agilent Technologies Inc., Santa Clara, CA, USA) with a YMC-Pack ODS-A column (5 μm, 250 mm × 4.6 mm; 5 μm, 250 mm × 10 mm, YMC CO., LTD., Japan). Medium-pressure liquid chromatography (MPLC) was performed on a Buchi Medium pressure preparative chromatography (BUCHI Labor Technik AG, Switzerland) equipped with a medium-pressure column containing YMC reversed-phase (RP)-C18 silica gel. Gel chromatography was carried out on a gel column with Sephadex LH-20 (40–70 μm; Amersham Pharmacia Biotech AB, Sweden). 1H, 13C, and 2D NMR data were acquired on a Bruker Avance Neo 400 MHz apparatus (Bruker Corporation, Faellanden, Switzerland).
+ Open protocol
+ Expand
4

Metabolomics Profiling by UPLC-Q Exactive Focus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolites were analyzed on a Q Exactive Focus instrument (Thermos Fisher Scientific, Waltham, MA, USA) equipped with a Vanquish UPLC. The metabolites were chromatographed on an Accucore aQ C18 column (150 × 2.1 mm, 2.6 µm, Thermos Fisher Scientific, Waltham, MA, USA). The mobile phase was 2% MeCN (containing 0.1% AcOH) for the first 2 min, then increased to 50% at 5 min, to 100% at 15 min, and then kept 100% for 2 min. Mass spectra were acquired using Full MS-AIF mode with resolutions 70,000. Ions were scanned from 70 to 1,000 m/z. AGC target was set to 1.0 × 106. The collision energy was set to 10, 20, 40 V for AIF. The MS raw data were recorded in profile type.
+ Open protocol
+ Expand
5

UHPLC-based Mycotoxin Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Qualitative and quantitative profile of mycotoxins has been obtained using ultra-high-performance liquid chromatography (UHPLC, Thermo Fisher Scientific, Waltham, MA, USA) equipped with a degassing system, a Dionex Ultimate 3000 a Quaternary UHPLC pump working at 1250 bar, an auto sampler device and a thermostated (T = 50 °C) Accucore aQ C18 column (100 × 2.1 mm 2.6 µm particle size), (Thermo Fisher Scientific, Bellefonte, PA, USA). Injection volume was 5 µL. Eluent phase was formed as follows: phase A (H2O in 0.1% formic acid and 5mM ammonium formate), phase B (methanol in 0.1% formic acid and 5mM ammonium formate). Analytes have been eluted using a 0.5 mL/min flow rate with the following programmed gradient: 0 min—60% of phase B, 9 min—100% of phase B, 12 min—100% of phase B, 12.1 min—60% of phase B, 15 min—60% of phase B.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!